NCT05362656 (AMPERE) is a NA clinical trial of VX1+ dispersion mapping in Atrial Fibrillation, sponsored by Volta Medical.

Who is sponsoring NCT05362656?

NCT05362656 is sponsored by Volta Medical.

What drugs are being tested in NCT05362656?

Interventions in NCT05362656: VX1+ dispersion mapping.

What condition does NCT05362656 study?

NCT05362656 studies Atrial Fibrillation, Atrial Tachycardia, Atrial Arrhythmia.

Is NCT05362656 still recruiting?

NCT05362656 is currently completed. Last updated 22 November 2023.

Last reviewed 2023-11-22 · How we verify

NCT05362656: AMPERE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

AutoMatic disPERsion Tagging Function Preliminary Evaluation

Completed NA Last updated 22 November 2023

What this trial tests

NA trial testing VX1+ dispersion mapping in Atrial Fibrillation in 40 participants. Completed in 9 December 2022.

Timeline

29 May 2022

Primary endpoint
9 December 2022

9 December 2022

Quick facts

Lead sponsor	Volta Medical
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	40
Start date	29 May 2022
Primary completion	9 December 2022
Estimated completion	9 December 2022
Sites	1 location across France

Drugs / interventions tested

VX1+ dispersion mapping

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →
Atrial Tachycardia — all drugs for Atrial Tachycardia →
Atrial Arrhythmia — all drugs for Atrial Arrhythmia →

Sponsor

Volta Medical

Who can join

18 and older, any sex, with Atrial Fibrillation or Atrial Tachycardia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Interventional, prospective, non-randomized, single-center, non-controlled clinical investigation as part of the premarket clinical evaluation of VX1+ medical device, aiming to verify that VX1+ in bidirectional configuration with auto-tagging function is both ergonomic and reliable for dispersed electrograms detection and automatic tagging on 3D-map in real-time.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Digital health technologies and artificial intelligence in cardiovascular clinical trials: A landscape of the European space.
Lampreia F, Madeira C, Dores H. · · 2024 · cited 4× · PMID 39291150 · DOI 10.1177/20552076241277703

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other Volta Medical trials

Trials by the same sponsor.

NCT06825104 — Long-Term Evaluation of TAILORED Vs Anatomical Ablation Strategy for Persistent Atrial Fibrillation · recruiting
NCT06083012 — Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation · active not recruiting
NCT05477147 — Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion · NA · completed
NCT04702451 — Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05362656 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Volta Medical
Last refreshed: 22 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05362656.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing